Search tips
ECCMID 2023
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
09 April 2016 - EV0441
In vitro activity of mecillinam alone and combined with different beta-lactams and/or beta-lactamase inhibitors against extended spectrum beta-lactamase- and AmpC-producing Escherichia coli and Klebsiella pneumoniae
Jan Tkadlec, Von Dach Elodie, Hansen Frank, F. Hansen, A. Hammerum, H. Hasman, N. Frimodt-Moller, A. Larsen
28 April 2013 - P1615
Activity of aztreonam combined with the beta-lactamase inhibitor avibactam tested against metallo beta-lactamase-producing organisms
Mariana Castanheira, M. Castanheira*, H.S. Sader, R.K. Flamm, R.N. Jones, M.D. Huband (North Liberty, Waltham, US)
28 April 2013 - P1616
In vitro antibacterial activity of aztreonam-avibactam against isogenic strains expressing single beta-lactamases and metallo beta-lactamase-producing clinical isolates
Michael Huband, M.D. Huband, R.A. Giacobbe, B. Andrews, L.G. Otterson, M. Uria-Nickelsen, L. Hajec, R. McLaughlin, P. Bradford (Waltham, US)
28 April 2013 - P1617
Pharmacokinetic/pharmacodynamic investigation of a novel combination: aztreonam-avibactam against Enterobacteriaceae isolates harbouring New Delhi metallo beta-lactamase
Renu Singh, R. Singh, M.A. Tanudra, M.-E. Beaudoin, R. Alm, A.E. Eakin, J.P. O\'Donnell* (Waltham, US)
28 April 2013 - P1618
In vitro activity of ceftaroline against Gram-positive and Gram-negative pathogens obtained from hospitalised, skin-infected patients in Germany, 2011-2012
Michael Kresken, M. Kresken*, B. Körber-Irrgang on behalf of the German Ceftarolin Study Group
28 April 2013 - P1619
Antimicrobial activity of ceftaroline and comparator agents tested against organisms causing skin and soft tissue infections in European medical centres (2011)
Raphaël Lecomte, H.S. Sader*, R.K. Flamm, R.N. Jones (North Liberty, US)
28 April 2013 - P1620
Antimicrobial activity of ceftaroline combined with avibactam tested against contemporary (2012) bacteria collected from USA patients with acute bacterial skin and skin structure infections (ABSSSI)
Helio S. Sader, H.S. Sader*, R.K. Flamm, R.N. Jones (North Liberty, US)
28 April 2013 - P1621
Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens (2008-2011)
Helio S. Sader, R.N. Jones, H.S. Sader*, M.G. Stilwell, R.K. Flamm (North Liberty, US)
28 April 2013 - P1622
Activity of ceftaroline against the leading community-acquired respiratory tract infection pathogens in Europe and the Mediterranean region, 2011
Raphaël Lecomte, R.K. Flamm*, H.S. Sader, R.N. Jones (North Liberty, US)
28 April 2013 - P1623
The 2011 Australian Group on Antimicrobial Resistance (AGAR) hospital-onset Staphylococcus aureus ceftaroline-susceptibility surveillance programme
John Turnidge, G. Coombs*, J. Turnidge, J. Pearson, K. Christiansen (Perth, North Adelaide, AU)
28 April 2013 - P1624
In vitro activities of ceftaroline and ceftaroline-avibactam against aerobic and anaerobic bacteria recovered from diabetic foot infections
Diane M. Citron, D.M. Citron*, E.J.C. Goldstein (Culver City, US)
28 April 2013 - P1625
Activity of ceftobiprole tested against pathogens associated with hospital-acquired bacterial pneumonia in Europe
Raphaël Lecomte, R.K. Flamm*, H.S. Sader, J.M. Streit, R.N. Jones (North Liberty, US)
28 April 2013 - P1626
Activity of ceftobiprole tested against pathogens associated with community-acquired bacterial pneumonia in Europe
Raphaël Lecomte, R.K. Flamm*, H.S. Sader, R.N. Jones (North Liberty, US)
28 April 2013 - P1627
Activity of ceftobiprole tested against Gram-negative clinical isolates from European medical centres
Raphaël Lecomte, R.K. Flamm*, H.S. Sader, J.M. Streit, R.N. Jones (North Liberty, US)
28 April 2013 - P1628
Activity of ceftobiprole tested against clinical isolates of staphylococci and streptococci from European surveillance (2008-2010)
Raphaël Lecomte, R.K. Flamm*, H.S. Sader, J.M. Streit, R.N. Jones (North Liberty, US)
28 April 2013 - P1629
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus including strains with reduced susceptibility to daptomycin, linezolid, and vancomycin
Raphaël Lecomte, R.K. Flamm*, R.E. Mendes, H.S. Sader, R.N. Jones (North Liberty, US)
28 April 2013 - P1630
Antimicrobial activity of ceftolozane/tazobactam and comparator agents tested against Pseudomonas aeruginosa isolates from 14 European countries and Israel
Helio S. Sader, H.S. Sader*, M. Castanheira, R.K. Flamm, R.N. Jones (North Liberty, US)
28 April 2013 - P1631
BAL30072 combined with meropenem exhibits synergistic bactericidal activity against clinical New Delhi metallo beta-lactamase (NDM-1)-positive Enterobacteriaceae
William Stubbings, J. Weeks, W. Stubbings, T.R. Walsh* (Cardiff, UK; Basel, CH)
28 April 2013 - P1632
Biapenem plus the beta-lactamase-inhibitor RPX7009 for multidrug-resistant Gram-negative pathogens
Olga Lomovskaya, O. Lomovskaya*, P. King, D. Sun, D. Griffith, S. Hecker, M. Dudley (San Diego, US)
28 April 2013 - P1634
Toxin-antitoxin system: a key for antibacterial targets among Acinetobacter baumannii
Sekawi Zamberi, Z. Sekawi*, S. Ghafourian, V. Neela, N. Sadeghifard, M. Raftari (Putra, MY; Ilam, IR)
Loading ...
FAQ
To access content in the eLibrary you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ECCMID where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.